Clinical trial Recruiting at 1 site Interventional Ages 19 and up

12-mm Partially Covered vs Bare Self-Expandable Stents for Malignant Distal Biliary Obstruction

Official title: 12-mm Partial Covered Versus Bare Self-Expandable Metallic Stents for Malignant Distal Biliary Obstruction: A Prospective, Randomized Clinical Study

Run by Chung-Ang University Hospital · NCT07559968 · Data updated 2026-11-12

This study tests whether a 12-mm partially covered self-expandable stent works better than a 12-mm bare self-expandable stent for patients with unresectable malignant distal biliary obstruction who have already had PTBD.

More Biliary Obstruction trials

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment60 (estimated)
SponsorChung-Ang University Hospital
Academic / other
Locations1 site (Seoul, Seoul)
StatusRecruiting
StartedMay 27, 2026
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedJuly 13, 2026
Trial IDNCT07559968 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 19 years and older with unresectable malignant distal biliary obstruction who have already undergone PTBD and are planned for metallic stent placement through the PTBD tract.

Probably not a fit

Patients with prior biliary metallic stent placement, hilar obstruction, or other major biliary lesions may not benefit from the study interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized trial compares two 12-mm self-expandable metallic stents in adults with unresectable malignant distal biliary obstruction who have undergone PTBD. Participants are randomly assigned to receive either a partially covered or a bare stent through the existing PTBD tract and are followed for 12 months with assessments at 3, 6, and 12 months. Outcomes include recurrent biliary obstruction, stent patency, need for reintervention, overall survival, and procedure-related complications. The study aims to provide evidence to guide selection of the more effective and safe 12-mm stent type in this palliative setting. It is a single-center trial sponsored by Chung-Ang University Hospital with collaboration from OSYMED Co., Ltd.

Why it matters

Potential benefit: If successful, the trial could identify the stent type that provides longer patency and fewer complications, improving quality of life for patients with unresectable malignant distal biliary obstruction.

How similar studies have gone: Previous work has explored 10-mm stents with mixed results; this trial extends evaluation to 12-mm stents to determine comparative effectiveness and safety.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who voluntarily provide written informed consent after receiving sufficient explanation of the study purpose, methods, and potential benefits and risks
* Adults aged 19 years or older
* Patients diagnosed with unresectable malignant distal biliary obstruction based on imaging studies (CT, MRI, ERCP, etc.) or histologic confirmation
* Patients who have already undergone percutaneous transhepatic biliary drainage (PTBD) according to the institutional clinical protocol and are scheduled for metallic stent placement through the existing PTBD tract

Exclusion Criteria:

* Patients with a previous history of biliary metallic stent placement
* Patients with upper biliary obstruction (hilar level or above)
* Patients with other major biliary lesions in addition to malignant distal biliary obstruction
* Patients for whom the investigator judges that study conduct or data collection would be markedly difficult

Where it's running

  • Chung-Ang university Hospital
    Seoul, Seoul, South Korea
    Recruiting

Study contacts

  • Principal investigator: Woosun Choi, MD, PhD — Associate Professor, Department of Radiology, Chung-Ang University Hospital
  • Study coordinator: Woosun Choi, MD, PhD
  • Email: radiochoi527@gmail.com
  • Phone: +82-2-6299-2681

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.